Teva reports fourth quarter and full year 2020 financial results

Tel aviv, israel--(business wire)--teva pharmaceutical industries ltd. (nyse and tase: teva) today reported results for the year and the quarter ended december 31, 2020. q4 2020 and fy 2020 highlights:   q4 2020 fy 2020 revenues   $4.5 billion $16.7 billion cash flow from operating activities   $331 million $1,216 million free cash flow   $471 million $2,110 million gaap earnings (loss) per share   $0.14 $(3.64) non-gaap eps   $0.68 $2.57 2021 business outlook: revenues are expected to be $16.4
TEVA Ratings Summary
TEVA Quant Ranking